Table S4.
Association of risk groups with CRT and cumulative MTX and GC dose
| Risk | P-value | |||
|---|---|---|---|---|
| Standard | High | |||
| CRT | No | 90 (81.1%) | 9 (6.9%) | 1.3×10−31 |
| Yes | 21 (18.9%) | 122 (93.1%) | ||
| MTX Cumulative1 (mg/m2) | ≤6723 | 34 (30.6%) | 86(66.4%) | 2.6×10−8 |
| >6723 | 77(69.4%) | 43 (33.6%) | ||
| GC Cumulative (mg/m2) | ≤9025 | 106 (95.5%) | 14 (10.9%) | 4.5×10−39 |
| >9025 | 5 (4.5%) | 115 (89.1%) | ||
Note: 1Cumulative MTX and GC doses are recoded as above and below median.
Abbreviations: CRT, cranial radiation therapy; MTX, methotrexate; GC, glucocorticoids.